Nuclear Imaging Devices Market – Expanding Roles in Oncology, Cardiology, and Neurology

The nuclear imaging devices market is expanding its footprint across multiple clinical specialties, with oncology, cardiology, and neurology driving demand for advanced functional imaging. As precision medicine becomes the norm, nuclear imaging is increasingly used to guide treatment decisions, monitor response, and personalize therapy.

The market was valued at USD 8.27 billion in 2024 and is projected to reach USD 13.92 billion by 2032, growing at a CAGR of approximately 6.7%. Growth is fueled by the rising prevalence of cancer and cardiovascular diseases, increasing demand for early and accurate diagnosis, technological advancements in detector sensitivity and image resolution, and the integration of AI for image analysis and workflow optimization.

In oncology, PET and PET/CT are indispensable for cancer staging, restaging, and treatment response assessment. Novel radiotracers (e.g., PSMA for prostate cancer, DOTATATE for neuroendocrine tumors) are enabling more precise targeting and characterization of tumors. In cardiology, SPECT and PET are used to assess myocardial perfusion, viability, and inflammation, guiding revascularization decisions and risk stratification. In neurology, nuclear imaging is critical for diagnosing dementia (Alzheimer’s, Parkinson’s), epilepsy, and movement disorders, often before structural changes are visible on MRI or CT.

End users are led by hospitals, which handle complex cases and high patient volumes. Diagnostic imaging centers are emerging as key growth areas, offering specialized, outpatient-focused services.

Regionally, North America leads, supported by advanced healthcare infrastructure and high adoption of cutting-edge technologies. Europe follows with strong clinical networks. Asia-Pacific is the fastest-growing region, driven by rising healthcare expenditure, increasing cancer burden, and expanding diagnostic capabilities.

Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Curium, Mediso, Bruker, and others. Strategies focus on developing next-generation detectors, AI-powered analytics, and expanding access in emerging markets.

Read more: Nuclear Imaging Devices Market Growth, Size, Report 2032

People Also Ask

Q1. How is nuclear imaging used in oncology?
Nuclear imaging (especially PET) is used for cancer staging, restaging, treatment response assessment, and detecting recurrence, often with novel radiotracers that target specific tumor markers.

Q2. What are the main neurological applications of nuclear imaging?
Main applications include diagnosing dementia (Alzheimer’s, Parkinson’s), epilepsy localization, and assessing movement disorders, often before structural changes are visible on conventional imaging.

Tags: nuclear imaging, oncology diagnostics, cardiology imaging, neurology imaging, PET scanners, SPECT imaging